These findings underscore the need for systematic financial risk screening and the development of German-specific assessment tools to address the socioeconomic burden in cancer care.
Hecht et al. (Sun,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: